About Joslin | Patient Care | Supporting Joslin
Albert Hwa, Ph.D., is the Operations Director for Joslin's Center for Cell-Based Therapy for Diabetes (CCTD). Dr. Hwa will work with the center director and Joslin's senior leadership to identify technologies ripe for translation and establish the research programs to bring them to clinical testing. Beta cells will be a primary target for the center for its central role in correcting insulin insufficiency in diabetes. CCTD will also try to accelerate and translate advances made in cell therapies for wound healing and eye diseases.
For the first initiative, Joslin is partnering with other leading Boston institutions in academia and industry to bring stem cell-derived beta cell replacement to clinical testing. Dr. Hwa will be the overall program manager and coordinate the research activities. Additionally, Dr. Hwa will perform similar duties for other future research programs under CCTD.
Dr. Hwa came to Joslin from JDRF, where he was Director of Discovery Science. He has extensive experience in program planning and implementation, and has been involved in managing large research consortia, including the European Consortium for Islet Transplantation and the Islet Transplantation Program in Australia.
In addition, Dr. Hwa:
Office Phone Number: 1-617-309-2573